StephenJKanesMD
Psychiatry • Swarthmore, PAAssistant Professor, Department of Psychology, University of Pennsylvania
Dr. Kanes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Guernsey Rd
Swarthmore, PA 19081Phone+1 610-690-0336- Is this information wrong?
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 1995 - 1999
Stony Brook University Health Sciences Center School of MedicineClass of 1995
Certifications & Licensure
PA State Medical License 1999 - 2018
CT State Medical License 1997 - 2017
Clinical Trials
- Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers Start of enrollment: 2010 May 01
- Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 Start of enrollment: 2010 Mar 01
- Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus Start of enrollment: 2014 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsAssociations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.Margaret E. Gerbasi, Adi Eldar-Lissai, Sarah Acaster, Moshe Fridman, Vijayveer Bonthapally, Paul Hodgkins, Stephen Kanes, Samantha Meltzer-Brody> ;Archives of Women's Mental Health. 2020 Jul 14
- 69 citationsAllopregnanolone in postpartum depression: Role in pathophysiology and treatment.Samantha Meltzer-Brody, Stephen Kanes> ;Neurobiology of Stress. 2020 May 1
- 32 citationsSAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.Ethan Hoffmann, George G. Nomikos, Inder Kaul, Shane Raines, Jeff Wald, Amy Bullock, Abdul J. Sankoh, James J. Doherty, Stephen Kanes, Helen Colquhoun> ;Clinical Pharmacokinetics. 2020 Jan 1
- Join now to see all
Authored Content
- S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018
- S100. Efficacy and Safety of Brexanolone IV Across Phase 2/3 Studies: A First-in-Class GABAA Receptor Positive Allosteric Modulator for Postpartum DepressionApril 2018
Press Mentions
Shit Happens with the a TeamSeptember 16th, 2022- Brexanolone: A Possible Novel Treatment in Severe Postpartum DepressionJuly 13th, 2017
Grant Support
- Olfaction: A Novel Mouse Model Of SchizophreniaNational Institute Of Mental Health2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
